Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Quoin Pharmaceuticals Ltd ADR (NQ: QNRX ) 0.4986 UNCHANGED Streaming Delayed Price Updated: 3:57 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Quoin Pharmaceuticals Ltd ADR REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome October 24, 2023 From Quoin Pharmaceuticals, Inc. Via GlobeNewswire Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics August 17, 2023 From PCG Digital Via ACN Newswire Quoin Pharmaceuticals' Commitment to Delivering Treatment for Netherton Syndrome Patients and Creating Value for Shareholders August 09, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Asensus Shares First Quarter Results and Future Plans June 01, 2023 From PCG Digital Via ACN Newswire A Pivotal Year Ahead for Quoin Pharmaceuticals March 01, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Quoin Pharmaceuticals: Strategically Building For Future Success June 14, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug June 06, 2022 LAS VEGAS, NV / ACCESSWIRE / June 6, 2022 / Skinvisible, Inc. ("Skinvisible") (OTCQB:SKVI), is pleased to announce that its licensee Quoin Pharmaceuticals, Inc. ("Quoin") (NASDAQ:QNRX), has received... From Skinvisible Inc Via AccessWire Exposures Product Safety Quoin Pharmaceuticals Targeting Regulatory Approvals for Lead Candidate for Netherton Syndrome in 2024 March 24, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Changing Lives, Delivering Value: Quoin Pharmaceuticals is Making the Balancing Act Look Easy February 08, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Quoin Pharmaceuticals Poised for Rapid Commercialization of Promising Pipeline November 16, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.